QA: Amicus Therapeutics INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2023_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 423,816,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 30,778,000
3 remainder_Assets 48,776,000
4 LiabilitiesCurrent 139,018,000
5 LiabilitiesNoncurrent 60,517,000
6 remainder_Liabilities 401,585,000
7 CostOfGoodsAndServicesSold 44,741,702
8 SellingGeneralAndAdministrativeExpense 229,660,011
9 ResearchAndDevelopmentExpense 279,502,155
10 remainder_Expenses 47,474,309
11 remainder_Revenues 332,599,784
12 remainder_NetIncome 4,283,976
13 remainder_ComprehensiveNetIncome -21,790,919
  yvar yval
0 Assets 724,167,000
1 Liabilities 601,120,000
2 Expenses 601,378,177
3 Revenues 332,599,784
4 StockholdersEquity 123,047,000
5 NetIncome -264,494,417
6 ComprehensiveNetIncome -275,389,876
7 BaseVar 1,142,669,928
8 EconomicCapitalRatiobeforeLimitedLiability -0.0108
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time